Skip to main content
. Author manuscript; available in PMC: 2020 Jan 8.
Published in final edited form as: Cell Rep. 2019 Feb 12;26(7):1869–1879.e3. doi: 10.1016/j.celrep.2019.01.066

Figure 4. NaCl-Primed or Normal iTregs Inhibit Differentiation of Pathogenic Cells in Inflammatory Colitis and Prevent Pathogenic Cells from Infiltrating to Colon.

Figure 4.

(A) Colitis mice were sacrificed at 6 weeks after cell administration, and CD4+ cells from the spleen (SP) and mesenteric lymph nodes (mLN) were examined. Flow cytometric analysis and frequencies of IL-17A+CD90.2+ and IFNγ+CD90.2+ cells were examined in the respective mouse groups (6 mice in each group in one experiment).

(B) The bar graph depicts a summary of the experiment (6 mice in each group in one experiment).

(C) The infiltrating cells in large intestines (LP) were analyzed on total CD4+ T cells.

(D) The bar graph depicts a summary of the experiment (6 mice in each group in one experiment).

(E) On day 35 and 45 after cells transfer, iTreg Foxp3 loss were compared in SP and LN, cells were gated on CD90.1+. Representative results (mean ± SEM) from four independent experiments are shown.

(F) The line graph depicts a summary of the experiment (6 mice in each group in one experiment). Statistical analyses were performed using one-way ANOVA. *p < 0.05; **p < 0.01; ***p < 0.001; ns, not significant.